The full text of this item is not currently available in HELIOS
|Title:||Differential estrogen receptor subtype modulators: Assessment of estrogen receptor subtype-bincling selectivity and transcription-regulating properties of new cycloalkyl pyrazoles|
Kasiotis, Konstantinos M.
Meligova, Aggeliki K.
Haroutounian, Serkos A.
Alexis, Michael N.
|Type:||Journal Article (Scientific Journal article)|
|Abstract:||Several new cycloalkyl-fused diaryl pyrazoles were synthesized and their binding affinity for the estrogen receptor (ER) subtypes, ER alpha and ER beta, and subtype-specific agonist/antagonist properties were determined. Cyclopentane- and cyclohexane-fused pyrazoles with p-hydroxyphenyl rings at positions 1 and 3 displayed modest ER beta-binding selectivity and variable agonism through ER alpha, while behavingas full estrogen antagonists through ER beta in estrogen-responsive element (ERE)-dependent gene expression assays. By contrast, the 2,3-diphenolic derivatives were non-selective and considerably less effective ER beta antagonists compared to 1,3-diphenolic ones. The cyclohexane-fused 1,3-diphenolic pyrazole 8, in particular, behaved as full ER alpha agonist/ER beta antagonist in these assays. Molecular modelling revealed the structural determinants possibly accounting for the differential regulation of transcription through the two ERs exhibited by 8. The data also shows that the ER subtype-binding selectivity and agonist/antagonist efficacy of the 1,3-diphenolic pyrazoles is influenced by the cycloalkyl ring fused to the pyrazole core. Using 8 we show that, though the mutant androgen receptor (AR) of LNCaP cells is required for estrogen as well as androgen stimulation of cell growth, estrogen responsiveness of the cells depends on ER beta and AR but not on ER alpha.|
|Journal Title:||Journal of Steroid Biochemistry and Molecular Biology, the (formerly Known as Journal of Steroid Biochemistry)|
|Subject Category:||Science::Biology (General)|
|Keywords:||Cycloalkyl-fused pyrazoles; Estrogen receptor modulators; MCF-7; LNCaP; Endocrinology & Metabolism|
|Other Identifiers:||DOI: http://dx.doi.org/10.1016/j.jsbmb.2009.09.006|
|Journal web Location :||http://www.elsevier.com/locate/jsbmb|
|Rights holder:||© 2009 Elsevier Ltd. All rights reserved.|